Development of folic acid modified reduction-responsive micelles for the targeted release of sorafenib in liver cancer
These results demonstrated the feasibility of SAF-FDCS micelles in inhibiting tumor growth and their superiority in anti-cancer effects compared to free drugs and normal micelles.
Authors
- Yanqiu Hu (ORCID: https://orcid.org/0000-0001-9095-4876)
- Xingyu Hou (ORCID: https://orcid.org/0000-0002-1098-0984)
- Kunpeng Shi
- Yang Yu (ORCID: https://orcid.org/0000-0001-9052-1245)
- Weitong Sun (ORCID: https://orcid.org/0000-0001-9462-8509)
- Lixin Fan
Institutions
- Jiamusi University (CN)
- First Affiliated Hospital of Jiamusi University (CN)
Publication Details
- Journal
- Therapeutic Delivery
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1080/20415990.2025.2513223
- Citations
- 1
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.60
Funders
- Natural Science Foundation of Heilongjiang Province